Clinical Trial Update: A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

View source ↗

Summary

A completed post-marketing safety study evaluating GSK's Poliorix (inactivated poliovirus vaccine) in Korean children to monitor safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Poliorix (inactivated poliovirus vaccine (IPV))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Poliomyelitis | Status: COMPLETED